Patent & IP news for September 16, 2009

The Onion Gets a Patent from www.1201tuesday.com

No, not that Onion. But by the time you finish reading this post (and you really should finish reading this post), you'll have to wonder... Timed perfectly to coincide with today's Federal Circuit ...

Share via E–mail | Twitter | Facebook

Prime Patents for Amazon from www.1201tuesday.com

There's no shortage of Amazon watchers who are quick to pounce on news of its patents and applications. So I'm guessing there will be at least some articles (probably a Slashdot posting) in ...

Share via E–mail | Twitter | Facebook

Lord Hoffmann in agreement with Tufty the Cat on software patents? from ipkitten.blogspot.com

The IPKat was very pleased to receive this morning an email from his "Sydney correspondent", Thai Loi at the University of New South Wales, which he kindly passed on to me. Thai writes:

"I had ...

Share via E–mail | Twitter | Facebook

Why anonymization doesn’t protect privacy from www.iposgoode.ca

Three years ago, Netflix released a database containing the movie preferences of 480,000 users. Last year, Google released information on the viewing habits of millions of YouTube users to Viacom. In both of these ...

Share via E–mail | Twitter | Facebook

Pharmalicensing.com from honoringtheinventor.blogspot.com

The well-crafted www.Pharmalicensing.com is a division of UTEK Corporation; a business development company that has created a progressive open innovation business model to help companies grow rapidly with university, research laboratory and corporate ...

Share via E–mail | Twitter | Facebook

Amgen and Mircera from ipbiz.blogspot.com

from the AP:

Thousand Oaks, Calif.-based Amgen ( AMGN - news - people ) said the Boston-based 1st U.S. Circuit Court of Appeals ruled that the Roche ( RHHBY.PK - news - people ) Group's rival product, Mircera, infringes ...

Share via E–mail | Twitter | Facebook

Unitemized Invoice Sinks Claim for $419,000 in Costs from docketreport.blogspot.com

The court reduced the costs awarded to defendant by $419,105 for visual aids. "[B]ecause the invoices are not itemized, there is no record of which visual aids correspond to each invoice. . . . It is ...

Share via E–mail | Twitter | Facebook

CAFC: A Divisional By Any Other Name Is Not a Divisional from www.ipwatchdog.com

The Federal Circuit, in Amgen Inc. v. F. Hoffman-La Roche Ltd, has made it clear that you had better characterize an application as a “divisional” if you want to the benefit of the “safe harbor ...

Share via E–mail | Twitter | Facebook

QuickJump – software I can’t live without from inventblog.com

I previously mentioned QuickJump in an earlier post, back when QuickJump was still in beta. I had been using it for a few days when I wrote that post, and I’m still using it ...

Share via E–mail | Twitter | Facebook

Amgen v. Hoffman-La Roche: Checking the Wrong Box Could Prove Costly for Amgen from holmansbiotechipblog.blogspot.com

Yesterday the Federal Circuit issued a decision in Amgen v. Hoffman-La Roche, an important case arising out of Amgen’s efforts to block Roche from entering the US market with a competing version of recombinant ...

Share via E–mail | Twitter | Facebook

Prometheus Prevails in a Victory for Biotechnology and Personalized Medicine from holmansbiotechipblog.blogspot.com

In past posts I have discussed Prometheus v. Mayo, which addresses the issue of whether a diagnostic method for providing personalized therapeutic treatment is patent eligible under Bilski (click here for background on the case ...

Share via E–mail | Twitter | Facebook

Patented Methods Can Include Mental Steps from www.patentbaristas.com

The Prometheus v. Mayo case, what Hal Wegner calls “Metabolite déjà vu II,” has represented perhaps the most troubling development for medical treatment patents in recent times. The case concerns a patent for a means ...

Share via E–mail | Twitter | Facebook

Patentable Subject Matter: Federal Circuit Upholds Patentability of Drug Dosage Method Claim from www.patentlyo.com

Prometheus Labs. v. Mayo Clinic (Fed. Cir. 2009) In a unanimous panel opinion, the Federal Circuit has rejected Mayo's patentable subject matter challenge under 35 U.S.C. 101 - holding that the claimed methods ...

Share via E–mail | Twitter | Facebook

Blog coverage of Cisco/Frenkel trial in Texas from ipbiz.blogspot.com

In a 14 Sept 09 article in Texas Lawyer, Brenda Sapino Jeffreys writes:

Legal bloggers writing about intellectual property matters are sure to take note of a trial set to start on Sept. 14 in ...

Share via E–mail | Twitter | Facebook